These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12419502)

  • 41. Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease.
    Kaerst L; Kuhlmann A; Wedekind D; Stoeck K; Lange P; Zerr I
    J Alzheimers Dis; 2014; 38(1):63-73. PubMed ID: 23948928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
    Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
    Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.
    Reesink FE; Lemstra AW; van Dijk KD; Berendse HW; van de Berg WD; Klein M; Blankenstein MA; Scheltens P; Verbeek MM; van der Flier WM
    J Alzheimers Dis; 2010; 22(1):87-95. PubMed ID: 20847452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined L-citrulline and glutathione supplementation increases the concentration of markers indicative of nitric oxide synthesis.
    McKinley-Barnard S; Andre T; Morita M; Willoughby DS
    J Int Soc Sports Nutr; 2015; 12():27. PubMed ID: 26097441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Markedly elevated nitrate/nitrite levels in the cerebrospinal fluid of children with progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome).
    Vanhatalo S; Riikonen R
    Epilepsia; 2000 Jun; 41(6):705-8. PubMed ID: 10840402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity.
    Drulović J; Dujmović I; Mesaros S; Samardzić T; Maksimović D; Stojsavljević N; Lević Z; Mostarica Stojokvić M
    Mult Scler; 2001 Feb; 7(1):19-22. PubMed ID: 11321188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.
    Boström F; Hansson O; Blennow K; Gerhardsson L; Lundh T; Minthon L; Zetterberg H; Londos E
    Dement Geriatr Cogn Disord; 2009; 28(4):314-9. PubMed ID: 19844105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome.
    Sullivan KJ; Kissoon N; Duckworth LJ; Sandler E; Freeman B; Bayne E; Sylvester JE; Lima JJ
    Am J Respir Crit Care Med; 2001 Dec; 164(12):2186-90. PubMed ID: 11751185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients.
    Kuiper MA; Teerlink T; Visser JJ; Bergmans PL; Scheltens P; Wolters EC
    J Neural Transm (Vienna); 2000; 107(2):183-9. PubMed ID: 10847559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course.
    Svenningsson A; Petersson AS; Andersen O; Hansson GK
    Neurology; 1999 Nov; 53(8):1880-2. PubMed ID: 10563648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
    Herbert MK; Aerts MB; Kuiperij HB; Claassen JAHR; Spies PE; Esselink RAJ; Bloem BR; Verbeek MM
    Alzheimers Dement; 2014 Jul; 10(4):448-455.e2. PubMed ID: 24239248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered CSF orexin and α-synuclein levels in dementia patients.
    Wennström M; Londos E; Minthon L; Nielsen HM
    J Alzheimers Dis; 2012; 29(1):125-32. PubMed ID: 22207004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No changes in cerebrospinal fluid levels of nitrite, nitrate and cyclic GMP with aging. Short communication.
    Yamada K; Nishiwaki K; Hattori K; Senzaki K; Nagata M; Komatsu T; Shimada Y; Nabeshima T
    J Neural Transm (Vienna); 1997; 104(8-9):825-31. PubMed ID: 9451715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid nitric oxide metabolites in painful diseases.
    Kimura S; Watanabe K; Yajiri Y; Motegi T; Masuya Y; Shibuki K; Uchiyama S; Homma T; Takahashi HE
    Neuroreport; 1999 Feb; 10(2):275-9. PubMed ID: 10203321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide (NO) metabolism in the cerebrospinal fluid of patients with severe head injury. Inflammation as a possible cause of elevated no metabolites.
    Uzan M; Tanriover N; Bozkus H; Gumustas K; Guzel O; Kuday C
    Surg Neurol; 2001 Dec; 56(6):350-6. PubMed ID: 11755960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. alpha-Synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies.
    Ballard C; Jones EL; Londos E; Minthon L; Francis P; Aarsland D
    Int Psychogeriatr; 2010 Mar; 22(2):321-7. PubMed ID: 19747426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies - a systematic review and meta-analysis.
    Lim X; Yeo JM; Green A; Pal S
    Parkinsonism Relat Disord; 2013 Oct; 19(10):851-8. PubMed ID: 23886935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrospinal fluid nitrate levels in patients with multiple sclerosis.
    de Bustos F; Navarro JA; de Andrés C; Molina JA; Jiménez-Jiménez FJ; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Martínez-Salio A; Arenas J
    Eur Neurol; 1999 Jan; 41(1):44-7. PubMed ID: 9885328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
    Maetzler W; Stoycheva V; Schmid B; Schulte C; Hauser AK; Brockmann K; Melms A; Gasser T; Berg D
    J Alzheimers Dis; 2010; 22(3):933-8. PubMed ID: 20858953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.